SAFETY AND EFFECTIVENESS OF PEMETREXED IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IN JAPAN BASED ON POST-MARKETING SURVEILLANCE

被引：0
|
作者：
Okubo, Sumiko [1 ]
Kobayashi, Noriko [1 ]
Taketsuna, Masanori [1 ]
Enatsu, Sotaro [1 ]
Nishiuma, Shinichi [1 ]
机构：
[1] Eli Lilly Japan, Kobe, Hyogo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 11期
关键词：
Post-Marketing Surveillance; NSCLC; Pemetrexed;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-011
引用
收藏
页码：S485 / S485
页数：1
相关论文
共 50 条
  • [21] Safety and Effectiveness Analyses of Dolutegravir/Lamivudine in Patients with HIV: 2-Year Report of Post-Marketing Surveillance in Japan
    Tofukuji, Ayano
    Hongo, Haruyuki
    Nagao, Takako
    Sebata, Akemi
    Suzuki, Miwako
    Maeno, Yuko
    Kurosaki, Eiji
    Fukuda, Akiko
    Watanabe, Tomoyuki
    ADVANCES IN THERAPY, 2023, 40 (04) : 1884 - 1898
  • [22] Safety and effectiveness of tadalafil in pediatric patients with pulmonary arterial hypertension: a sub-group analysis based on Japan post-marketing surveillance
    Yamazaki, Hiroyoshi
    Kobayashi, Noriko
    Taketsuna, Masanori
    Tajima, Koyuki
    Suzuki, Nahoko
    Murakami, Masahiro
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (12) : 2241 - 2249
  • [23] Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study
    Motoo, Nagane
    Hayashi, Yasuko
    Shimizu, Ayaka
    Ura, Masako
    Nishikawa, Ryo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (11) : 1016 - 1023
  • [24] Safety and effectiveness of lenalidomide in Japanese patients with relapsed/refractory ATLL: post-marketing surveillance
    Miyazaki, Tohru
    Uno, Shuji
    Fujimori, Hiroaki
    Motegi, Yoko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025, 121 (01) : 79 - 88
  • [25] Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance
    Makoto Tahara
    Naomi Kiyota
    Ken-ichi Nibu
    Ayumi Akamatsu
    Tomohiro Hoshino
    Ryuichi Hayashi
    International Journal of Clinical Oncology, 2021, 26 : 1619 - 1627
  • [26] Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance
    Kuwana, Masataka
    Sugiyama, Naonobu
    Momohara, Shigeki
    Atsumi, Tatsuya
    Takei, Syuji
    Tamura, Naoto
    Harigai, Masayoshi
    Fujii, Takao
    Matsuno, Hiroaki
    Takeuchi, Tsutomu
    Yamamoto, Kazuhiko
    Takasaki, Yoshinari
    Tanigawa, Miki
    Endo, Yutaka
    Hirose, Tomohiro
    Morishima, Yosuke
    Yoshii, Noritoshi
    Mimori, Tsuneyo
    Takagi, Michiaki
    MODERN RHEUMATOLOGY, 2024, 34 (02) : 272 - 286
  • [27] Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance
    Shuichi Ito
    Yoshihiko Hidaka
    Norimitsu Inoue
    Shinya Kaname
    Hideki Kato
    Masanori Matsumoto
    Yoshitaka Miyakawa
    Masashi Mizuno
    Hirokazu Okada
    Akihiko Shimono
    Takahisa Matsuda
    Shoichi Maruyama
    Yoshihiro Fujimura
    Masaomi Nangaku
    Shoji Kagami
    Clinical and Experimental Nephrology, 2019, 23 : 112 - 121
  • [28] Safety and Effectiveness Analyses of Dolutegravir/Lamivudine in Patients with HIV: 2-Year Report of Post-Marketing Surveillance in Japan
    Ayano Tofukuji
    Haruyuki Hongo
    Takako Nagao
    Akemi Sebata
    Miwako Suzuki
    Yuko Maeno
    Eiji Kurosaki
    Akiko Fukuda
    Tomoyuki Watanabe
    Advances in Therapy, 2023, 40 (4) : 1884 - 1898
  • [29] Safety and effectiveness of eculizumab for adult patients with atypical hemolytic–uremic syndrome in Japan: interim analysis of post-marketing surveillance
    Hideki Kato
    Yoshitaka Miyakawa
    Yoshihiko Hidaka
    Norimitsu Inoue
    Shuichi Ito
    Shoji Kagami
    Shinya Kaname
    Masanori Matsumoto
    Masashi Mizuno
    Takahisa Matsuda
    Akihiko Shimono
    Shoichi Maruyama
    Yoshihiro Fujimura
    Masaomi Nangaku
    Hirokazu Okada
    Clinical and Experimental Nephrology, 2019, 23 : 65 - 75
  • [30] Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan
    Hiraizumi, Kenji
    Honda, Chikara
    Watanabe, Ayu
    Nakao, Takafumi
    Midorikawa, Shuichi
    Abe, Hiromi
    Matsui, Nobuki
    Yamamoto, Tsunehisa
    Sakamoto, Takahiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, : 932 - 943
12345